This is an example page. It’s different from a blog post because it will stay in one place and will shThe Ju-Snow Mechanobiology and Biomanufacturing Laboratory (MBL) at the University of Sydney is at the forefront of research in mechanobiology and biomanufacturing. Led by A/Prof Arnold Ju, the team is dedicated to advancing scientific knowledge and improving healthcare outcomes through the development of cutting-edge microtechnologies for cardiovascular health.
SUB-HEADING: Our research
Research topic – Biomechanical Nanotools
Our experts
Ms Laura Moldovan, Dr Yao Wang, Dr Mingxin Xu, Mr Haoqing (Jerry) Wang
Our partners
- Victor Chang Cardiac Research Institute
- Garvan Institute
- Baker Institute
- Heart Research Institute
- Lumicks
Research summary
Developing innovative biomechanical nanotools, such as the Biomembrane Force Probe (BFP) and fluorescent micropipette aspiration assays (fMPA), to elucidate cellular responses to mechanical stress and advance understanding of mechanobiological mechanisms in cardiovascular diseases.
Research topic – Organ-on-a-Chip Technology
Our experts
Linda Dei-Awuku, Zhao (Jeff) Wang, Zihao Wang, Yunduo (Charles) Zhao
Our partners
- Harvard Medical School
- University of Glasgow
- National University of Singapore
Industry partners
Australian biotech companies Research summary Pioneering personalised organ-on-a-chip devices, such as vessel-on-chip models, to simulate prothrombotic vascular geometries and provide insights into thrombosis and endothelial behaviour under stenotic conditions. These platforms aim to revolutionise drug evaluation and enhance the success rate of therapeutic interventions.
Research topic – Clinical Translation
Our experts
NHMRC Clinical Trials Centre (Prof Meg Jardine), University of Oxford (Prof David Beard)
Industry partners
- Sydney Biomedical Accelerator
Research summary
Leveraging expertise in mechanobiology and biomanufacturing to translate research findings into clinical applications through collaborations with leading clinical trial centres and industry partners. Addressing regulatory considerations and securing clinical champions to ensure the successful translation of technologies from concept to commercialisation.